Scroll Top
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Related Posts
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Related Posts
Doug Williams leaving Sana Plus: Baptista joins SmartCella and updates from LifeArc and Gain
BioCentury
Related Posts
Post navigation
Previous Post
Recent pharma industry appointments that should be on your radar
Next Post
Using AI to Create New Parkinson’s Treatments: Q&A with Matthias Alder
Latest Articles
Clear Filters
March 29, 2022
Cantor Rare Orphan Disease Summit
Read More
February 6, 2024
UPDATE – Gain Therapeutics’ GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson’s Disease
Read More
October 12, 2021
Gain Therapeutics and University of Maryland School of Medicine Announce Research Collaboration
Read More
Close